

浏览全部资源
扫码关注微信
1. 中国科学院上海原子核研究所
2. 中国科学院上海原子核研究所,上海,201800
Published:01 January 1992
移动端阅览
[1]唐国忠,赵夏令,周美英,殷林祥,杨建忠,胡根生.碘-125标记甲状腺激素衍生物的合成[J].核技术,1992(01):46-50.
Tang Guozhong Zhao Xialing Zhou Meiying Yin Linxiang Yang Jianzhong Hu Gensheng. Synthesis of 125I labelled derivatives of thyroxine and triiodothyronine for RIA[J]. Nuclear techniques, 1992, (1): 46-50.
以三碘甲腺原氨酸衍生物(T
3
X)和Na
125
I为原料
用氯胺-T法合成了
125
I-T
3
X和
125
I-T
4
X经HPLC分离纯化
产品的比活度:
125
I-T
3
X为16.87—31.78GBq/mg
125
I-T
4
X为31.15—46.07GBq/mg。该二种示踪剂已用于直接法放射免疫分析测定血中游离T
3
和游离T
4
浓度
并已证明
该衍生物虽经化学改性限制了与血清中内源蛋白的结合.但仍保持了T
3
、T
4
原有的与相应特异性抗体的结合特性。
Using triiodothyronine derivative(T3X) and Na 125I as starting materials
125I-T3X and 125I-T4X were synthesized by the chloramine-T method and separated by HPLC. The specific activity of products was 16.87-31.78GBq/mg for 125I-T3X and 3] 15-46.07 GBq/mg for 125I-T4X. The tracers have been used in the direct method of RIA for free T3 and free T4 in serum. It’s proved that the derivative
chemically modified to inhibit its binding to the endogenous serum proteins
still remain original binding characteristics of T3
T4 with the specific antiserum.
0
Views
76
下载量
3
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621